Endocrinology, Vol 128, 3253-3258, Copyright © 1991 by Endocrine Society

ARTICLES

Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment

HU Bryant, EW Bernton, JR Kenner and JW Holaday
Department of Immunology, Pulmonary and Leukotriene Research, Eli Lilly Co., Indianapolis, Indiana 46285.

Implantation of a 75-mg morphine pellet in sham-adrenalectomized male C3H/HeN mice resulted in significant elevations of serum corticosterone levels within 6 h. Corticosterone levels remained elevated (3- to 4- fold) for 72 h and had returned to normal by 120 h postimplantation. Within 48 h of pellet implantation, morphine-pelleted mice exhibited marked reductions in spleen (35%) and thymus weight (56%) relative to values in placebo-pelleted controls. In addition, adrenal hypertrophy was observed in the morphine-pelleted shams (50% increase in adrenal weight relative to placebo. The magnitude of splenic and thymic atrophy was reduced by about 50% in adrenalectomized morphine-pelleted mice (17% and 22% reductions, respectively) compared to that in adrenalectomized mice implanted with placebo pellets. Lymphocyte proliferative responses to the T-cell mitogen Concanavalin-A and the B- cell mitogen bacterial lipopolysaccharide were also significantly reduced in the morphine-pelleted sham mice. Morphine-induced suppression of Concanavalin-A- or lipopolysaccharide-stimulated lymphocyte proliferation was absent in adrenalectomized mice. Effects similar to adrenalectomy (e.g. lessening of magnitude of morphine- induced suppression of lymphoid organ weight and lymphocyte proliferation) were found in morphine-pelleted mice given the glucocorticoid receptor antagonist RU-486 at a dose of 10 mg/kg, twice daily. These studies imply that morphine-induced immunosuppression is at least in part mediated by the increase in serum corticosterone levels after implantation of the morphine pellet.

This article has been cited by other articles:

				J. Kelschenbach, R. A. Barke, and S. Roy Morphine Withdrawal Contributes to Th Cell Differentiation by Biasing Cells Toward the Th2 Lineage J. Immunol., August 15, 2005; 175(4): 2655 - 2665. [Abstract] [Full Text] [PDF]

				N. Zhang, D. Hodge, T. J. Rogers, and J. J. Oppenheim Ca2+-independent Protein Kinase Cs Mediate Heterologous Desensitization of Leukocyte Chemokine Receptors by Opioid Receptors J. Biol. Chem., April 4, 2003; 278(15): 12729 - 12736. [Abstract] [Full Text] [PDF]

				J. Wang, R. Charboneau, S. Balasubramanian, R. A. Barke, H. H. Loh, and S. Roy The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the {micro}-opioid receptor J. Leukoc. Biol., May 1, 2002; 71(5): 782 - 790. [Abstract] [Full Text] [PDF]

				J. M. Bidlack Detection and Function of Opioid Receptors on Cells from the Immune System Clin. Vaccine Immunol., September 1, 2000; 7(5): 719 - 723. [Full Text] [PDF]

				L. Zhang and T. J. Rogers {kappa}-Opioid Regulation of Thymocyte IL-7 Receptor and C-C Chemokine Receptor 2 Expression J. Immunol., May 15, 2000; 164(10): 5088 - 5093. [Abstract] [Full Text] [PDF]

				T. Yokota, K. Uehara, and Y. Nomoto Intrathecal morphine suppresses NK cell activity following abdominal surgery Can J Anesth, April 1, 2000; 47(4): 303 - 308. [Abstract] [Full Text] [PDF]

				K. Fukuzuka, C. K. Edwards III, M. Clare-Salzler, E. M. Copeland III, L. L. Moldawer, and D. W. Mozingo Glucocorticoid-induced, caspase-dependent organ apoptosis early after burn injury Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2000; 278(4): R1005 - R1018. [Abstract] [Full Text] [PDF]

				P. C. Singhal, P. Sharma, A. A. Kapasi, K. Reddy, N. Franki, and N. Gibbons Morphine Enhances Macrophage Apoptosis J. Immunol., February 15, 1998; 160(4): 1886 - 1893. [Abstract] [Full Text] [PDF]

				A. J. Eisch, M. Barrot, C. A. Schad, D. W. Self, and E. J. Nestler Opiates inhibit neurogenesis in the adult rat hippocampus PNAS, June 20, 2000; 97(13): 7579 - 7584. [Abstract] [Full Text] [PDF]